Skip to Main Content


Liver Transplants due to HCV decline dramatically

By | Leave a Comment

Liver transplants due to chronic HCV infections have declined dramatically. Non-alcoholic steatohepatitis (NASH) and alcohol liver disease are now the leading causes of liver transplants in the U.S.

While this decline can be credited to improvements in early screening and treatment of HCV, much more needs to be done to promote prevention, screening, and treatment to eliminate HCV as a public health threat.

Read the full article from Hep Magazine here.

Thematic Areas:

Comments are closed.

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.